Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin plus positive social interaction for young children with autism
ChiCTR1900023774Phase 2Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Autism Diagnostic Observation Schedule, Second Edition and Social Responsiveness Scale-2. Started Jun 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR1900023774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023774.